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Background: Shared decision making (SDM) research has emphasized the role of decision
aids (DAs) for helping patients make treatment decisions reflective of their preferences, yet
there have been few collaborative multi-institutional efforts to integrate DAs in orthopedic
consultations and primary care encounters.
Objective: In the context of routine DA implementation for SDM, we investigate which
patient-level characteristics are associated with patient preferences for surgery versus medical
management before and after exposure to DAs. We explored whether DA implementation in
primary care encounters was associatedwith greater shifts in patients’ treatment preferences after
exposure to DAs compared to DA implementation in orthopedic consultations.
Design: Retrospective cohort study.
Setting: 10 High Value Healthcare Collaborative (HVHC) health systems.
Study participants: A total of 495 hip and 1343 adult knee osteoarthritis patients who were
exposed to DAs within HVHC systems between July 2012 to June 2015.
Results: Nearly 20% of knee patients and 17% of hip patients remained uncertain about
their treatment preferences after viewing DAs. Older patients and patients with high pain
levels had an increased preference for surgery. Older patients receiving DAs from three
HVHC systems that transitioned DA implementation from orthopedics into primary care had
lower odds of preferring surgery after DA exposure compared to older patients in seven
HVHC systems that only implemented DAs for orthopedic consultations.
Conclusion: Patients’ treatment preferences were largely stable over time, highlighting that
DAs for SDM largely do not necessarily shift preferences. DAs and SDM processes should
be targeted at older adults and patients reporting high pain levels. Initiating treatment
conversations in primary versus specialty care settings may also have important implications
for engagement of patients in SDM via DAs.
Keywords: shared decision making, patient engagement, patient preferences, quality of care,
health systems, collaborative learning
Introduction
There is a growing interest in engaging patients to be more active participants in their
own care through shared decision making (SDM), a collaborative approach to clinical
decisions in which both physicians and patients contribute to conversations about the
best treatment choice given patients’ preferences and values.1 Many studies indicate
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that when patients are engaged in SDM, they not only
become more knowledgeable about their conditions but
they also experience less conflict about their treatment
choices.2,3 Moreover, patients who adopt active roles in
their care experience improved clinical outcomes and are
more likely to adhere to treatment plans.4
The use of patient decision aids (DAs) to facilitate
SDM has been of growing empirical interest through pol-
icy initiatives that seek to advance the role of patients in
medical decision-making. Although DAs – which often
take the form of pamphlets, videos, or web-based pro-
grams – do not guarantee that SDM occurs, dozens of
randomized trials have demonstrated that they are critical
tools for facilitating SDM.5 DAs are effective resources
for improving patients’ knowledge of their conditions and
engaging them as decision makers alongside clinicians in
treatment choices.3 A 2017 Cochrane systematic review
found a lower proportion of individuals reporting passive
roles in decision-making among patients exposed to DAs
compared with those not receiving DAs.6 DAs are parti-
cularly valuable for conditions such as total hip and knee
replacements where “there is a lack of clear evidence
showing superiority of one treatment, and treatment
choices vary in ways that may matter to patients”.7
DAs have been most widely tested among patients with
knee and/or hip osteoarthritis because these conditions are
highly preference sensitive, among the most commonly
performed orthopedic procedures in the US, and increas-
ingly costly procedures for commercially and publicly
insured patients.8 Initiating discussions about these trade-
offs critically shape patient awareness and expectations,9
and DAs are especially well suited to initiate conversations
about the possible benefits and risks associated with the
complicated choice between arthroplasty and medical
management.10 Studies across clinical settings from ortho-
pedic surgery11 to mental health12 underscore the role of
DAs in facilitating decisional certainty, or confidence for
a given patient to choose the most appropriate treatment
choice.13 Patients are less likely to experience regret or
dissatisfaction when they feel supported and confident in
their chosen treatment paths.14 These factors underlie the
importance of incorporating DAs into treatment trajec-
tories for these patients.
Despite a growing body of research emphasizing the role
of DAs in fostering alignment of patient preferences with
treatment decisions,15,16 there have been few large-scale
efforts to integrate them into routine clinical practice. As
a result, there is a dearth of evidence about treatment
preferences across patient subgroups in the context of routine
implementation of DAs to support SDM, especially across
diverse health systems.17 Emerging research suggests that
certain populations of patients might benefit from DAs to
support shared decisions about treatment choices. DAs to
support SDM may be especially helpful among older and
comorbid patients for whom treatment tradeoffs in light of
personal preferences may be especially complex,18–20 and for
whom improved treatment adherence and decision satisfaction
is especially important in helping achieve better health out-
comes for these vulnerable populations.21 Additionally, the
care context for shared decision making may also have impor-
tant implications for conversations about treatment prefer-
ences. Previous work indicates that, on average, surgeons
express the least support for SDM compared with other
specialists.22 Given the longitudinal nature of patients’ rela-
tionships with primary care physicians,23 conversations about
treatment benefits and risks may be more helpful to treatment
decisions when they occur upstream to a surgical consultation.
Aim
This cohort study utilizes patient data collected from the High
Value Healthcare Collaborative (HVHC) – a learning colla-
borative of health systems – that implemented DAs to support
SDM for hip and knee osteoarthritis patients. We investigate
which patient-level characteristics are associated with prefer-
ence for surgery following exposure to DAs intended to sup-
port SDM in routine care settings.Within the first month of the
project, three of the HVHC systems moved DA implementa-
tion from orthopedic consultations to primary care physician
encounters because of concerns about implementation fidelity
and wanted to focus on patients who are earlier in the treat-
ment decision-making process.24 Given variable implementa-
tion across the HVHC systems, we explore whether upstream
implementation of SDM in primary care in three systems is
associated with differing patient treatment preferences after
exposure to DAs compared to the seven systems that imple-
mented DAs within orthopedic practices.
Hypotheses
SDM research highlights the importance of patient character-
istics in influencing conversations about treatment prefer-
ences. Patient age, ethnicity, educational attainment as well
as the patient’s overall health status are hypothesized to shape
treatment decisions when exposed to DAs as part of the SDM
process.25 Research concerning treatment choices for elec-
tive surgeries has highlighted a decline in preference for such
surgeries with increasing patient age.26,27 Patient concerns
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about serious complications of surgeries, long recovery per-
iods and the need to rely upon others to help with post-
operative care are commonly cited explanations for older
patients to choose more conservative treatment modalities.28
Hypothesis 1: Uncertain older adult patients (aged 65
years and older) will be less likely to report a post-DA
preference for surgery compared with middle-aged
(51–64 year old) hip and knee patients.
The relationship between high pain levels and shifts in
treatment preferences remains an under-examined area.
Patients reporting worse scores on one assessment of
osteoarthritis severity and pain were more likely to have
chosen surgery over medical management,29 and knee
osteoarthritis patients were more likely to choose surgical
interventions when they reported more severe pain and
greater functional limitations compared with patients
reporting fewer impediments to activity and less pain.30
Hypothesis 2: Uncertain hip and knee patients who report
worse pain scores will be more likely to report
a preference for surgery post-DA intervention.
The intersection of comorbidity burden and decision-
making for preference-sensitive conditions has been a topic
of increasing investigation.31,32 Longitudinal studies of hip
and knee patients who underwent joint arthroplasties have
noted a trend toward greater comorbidity burden among this
group.33,34 Current estimates suggest that almost one half of
older adults live with three or more chronic conditions.18
Multimorbidity adds complexity to conversations about trade-
offs associated with treatment choices for preference-sensitive
conditions like osteoarthritis, elevating the importance of
tools such as DAs in helping to facilitate information
exchange in light of patient values. In light of these complex-
ities, we hypothesize that:
Hypothesis 3: Uncertain hip and knee patients with more
comorbidities will be less likely to report a preference for
surgery post-DA intervention.
We report methods and results in accordance with the
Strengthening of Reporting in Observational Studies in
Epidemiology (STROBE) guidelines for cohort studies.35
Methods
Study Setting and Participants
This retrospective cohort study leverages data collected
from 10 High Value Healthcare Collaborative (HVHC)
systems between July 2012 to June 2015, when HVHC
was awarded a Centers for Medicare and Medicaid
Innovation (CMMI) grant to implement DAs to support
SDM for patients considering surgery for hip or knee
osteoarthritis.36 This intervention was implemented in
orthopedic specialty practices and was in most cases “trig-
gered” by patients calling to make an appointment to
discuss treatment options for hip or knee osteoarthritis.
Patients viewed condition-specific DAs produced by
Health Dialog that addressed the risks and benefits of
surgery or medical management for hip or knee osteoar-
thritis and featured real patients as they discussed their
experiences and satisfaction with their treatment choices.
Health Dialog DAs have been widely utilized and
acknowledged as providing balanced information on the
benefits and tradeoffs of treatment trajectories for condi-
tions including hip and knee osteoarthritis.37,38 These DAs
could be viewed online, on DVD, or on a tablet in the
physician’s office prior to or following patients’ appoint-
ments. Health coaches, who were often trained nurses,
were able to address questions that arose for patients
viewing the DAs in-office.
Treatment preferences were assessed before and after DA
exposure. Patients completed pre-DA surveys that assessed
demographic information, pain scores, expectations for
health outcomes and treatment preferences (surgical vs non-
surgical vs unsure) before viewing DAs, while post-DA
surveys assessed treatment preferences after DA viewing.
These surveys were completed online if the patient viewed
the DA at home or on tablets if DAs were viewed in the
physician’s office. The Unified Data Extract –which includes
system-reported clinical records – captured information such
as ICD-9 codes used to construct Charlson comorbidity
scores. Among 6544 hip and knee patients with both health
records in HVHC’s Unified Data Extract and pre- and post-
DA patient survey records, 1343 knee patients and 495 hip
patients had complete pre- and post-DA surveys, resulting in
an analytic sample of 1838 patients.
The overarching goals of the project were to improve
the health status (as measured by pain and functioning) of
patients considering hip and knee interventions, to increase
the number of patients engaged in SDM, and to reduce
rates of hip and knee surgeries not reflective of patient
preferences.
Data Sources
The HVHC Unified Data Extract enables analysis of inpati-
ent and outpatient encounter-level data as well as ICD-9
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diagnosis codes for hip and knee osteoarthritis patients.39
The patient survey data include patient responses to ques-
tions assessing preferred treatment choices (before and after
DA viewing) as well as patient-reported Hip Disability and
Osteoarthritis Outcome Score (HOOS) and Knee Disability
and Osteoarthritis Outcome Score (KOOS) pain scores.
We utilized likelihood-based imputation to derive
values for patients with missing pain scores. For these
analyses, the patient cohort is restricted to those with
diagnoses of knee osteoarthritis (ICD-9 CM diagnostic
codes 715.09, 715.16, 715.26, 715.36 or 715.96) or hip
osteoarthritis (ICD-9 CM diagnostic codes 715.09, 715.15,
715.25, 715.35 or 715.95). All analyses were conducted in
parallel for the hip and knee cohorts. The Dartmouth
Institutional Review Board (IRB) approved a waiver of
consent for this study as it would not adversely affect the
rights and welfare of the subjects because: (1) data is
stored in limited data sets (de-identified except for dates
of service and ZIP codes) with direct patient identifiers
stored in a separate location; and (2) data analysis covered
under this study is for retrospective analysis only and the
research could not practicably be carried out without the
waiver of consent since the database houses only retro-
spective data across multiple health systems and obtaining
consent would not be feasible for a population of this size.
The HVHC Program Management Office can attest to the
study upholding all principles relating to patient confiden-
tiality, informed consent and IRB review in accordance
with the Declaration of Helsinki.
Measures
Outcome
Treatment Preferences Post-DA Exposure
Patient treatment preferences are captured in the following
question, asked before and after DA viewing: “At this time
[before or after viewing the DA], what treatment are you
leaning toward doing for your [hip/knee] pain?” The three
response categories are: [hip/knee] surgery, non-surgical
treatment, or not sure. We assessed preference for surgery
by patients’ post-DA response.
Independent Variables
We account for pre-DA exposure treatment preferences by
including variables representing 1) uncertainty before
exposure to the DAs, 2) whether patients report differences
in treatment preferences before and after the DA (from
uncertainty toward a preference, or from one preference to
another), and 3) changes in decision making stage. To
assess decision making stage, patients were asked before
and after DA viewing: “How far along are you with this
decision?” Patients reported one of four categories: [1]
“Not yet thought about all the options,” [2] “Considering
the different options,” [3] “Close to choosing an option,”
or [4] “Already chose an option.” We constructed an
ordinal outcome, where shifts in decision stage are char-
acterized as a decrease (moving down in the numbered
response, i.e. from [3] to [2]), a stable response (the same
numbered response reported before and after DA viewing),
or an increase (moving up in numbered response).
The patient surveys assessed patient age and the Hip
Disability and Osteoarthritis Outcome Score (HOOS) and
Knee Disability and Osteoarthritis Outcome Score
(KOOS). The HOOS and KOOS pain subscales, which
consist of 10 and 9 items, respectively, were normalized
on a 0–100 scale, where 0 indicates no pain and 100
indicates extreme hip or knee pain. The HOOS and
KOOS surveys have been well validated and demonstrated
to be reliable in assessing both short- and long-term pain
relating to osteoarthritis.40
The Charlson Comorbidity Index (CCI) was calculated
using encounter data to characterize the comorbidity bur-
den of the hip and knee osteoarthritis patients included in
our sample. The CCI is a continuous measure that weights
the sum of 17 comorbid conditions.41
We control for patient sex, race/ethnicity, marital status,
and education level in adjusted analyses. Prior literature
exploring the association between patient characteristics
and treatment decisions after SDM suggests that patient
preferences for surgical interventions are influenced by
patient sex, with females slightly more likely to express
a tendency toward conservative (non-surgical) treatment
options when compared with males.42,43 A patient’s social
support system – in particular having a spouse – also plays
a notable role in patient decision-making. Spouses contribute
another voice to the dialogue concerning treatment benefits
and disadvantages at the same time that they often assume
some responsibility for the patient’s ongoing care.44 We
control for patient race in light of research showing that non-
white patients are less likely to choose surgery compared
with white patients, possibly because of differing perceptions
of risk-to-benefit ratios11 Patients with higher educational
attainment may be more likely to actively engage in SDM
than less well-educated patients.45 To the extent that educa-
tion serves as a marker of socio-economic (as well as insur-
ance) status, these patients may also experience fewer
financial impediments should they decide to pursue surgery.
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Statistical Analyses
Patient characteristics were compared by post-DA prefer-
ence using chi-square analysis for dichotomous variables
and analysis of variance (ANOVA) for continuous out-
comes, with robust standard errors to account for patient
clustering within systems. Due to small cell sizes for hip
patients, some independent variable categories are col-
lapsed differently than for knee patients (i.e. age categories
for hip patients are Under 64 and 65+, while age cate-
gories for knee patients are Under 50, 50–64, and 65+).
We assessed the relationship between DA exposure and
treatment preference for surgery across patient subgroups
using multivariable logistic regression models that adjusted
for patient-level control variables and health system fixed
effects to account for patient clustering within systems.
Likelihood-based multiple imputation incorporating all con-
trol variables was employed to address missing data from
HOOS and KOOS pain scores across health systems.46
Results were averaged across 5 imputed data sets.
To explore whether upstream implementation in pri-
mary care across three systems is associated with shifts in
the relationship between patient-level variables and post-
DA treatment preferences compared with the full sample
of patients across all HVHC systems, we restricted the
analyses to the three systems.
Results
Descriptive statistics for the knee and hip patients across
all HVHC systems are reported in Table 1. The mean age
among knee patients was 59.3 years (SD = 9.6); among hip
patients, it was 58.5 years (SD = 10.1). Across condition
and preference categories, patients under the age of 65
comprised a larger segment of the study population com-
pared with older patient (over 70% of the hip and knee
patient populations, respectively). The majority of patients
were female (64.5% among knee patients and 56.2%
among hip patients) and Caucasian (82% of both knee
and hip patients). The mean Charlson Comorbidity Index
(CCI) across hip and knee patients was less than 2 (1.40
among hip patients and 1.38 among knee patients).
Whereas less than half (48%) of the entire sample of
knee patients expressed a post-DA preference for surgery,
63% of hip patients preferred surgery after exposure to
DAs. Among hip patients, 4.4% went from an uncertain
preference to a preference for surgery, while half that
number (2.2%) of hip patients switched from an uncertain
preference to a preference for non-surgical intervention.
Similarly, among the knee cohort, 4.1% of patients went
from an uncertain preference to a preference for surgery.
A slightly higher number of knee patients (5.3%) com-
pared with hip patients switched from an uncertain pre-
ference to a preference for non-surgical intervention.
Notably, the majority of knee (84.5%) and hip patients
(88.5%) maintained stable preferences both pre- and post-
DA exposure.
In adjusted analyses of post-DA treatment preferences
(reported in Table 2), knee patients aged 65 and older had
lower odds of choosing surgery after DA exposure compared
with patients aged 50–64 (OR = 0.79, p = 0.4). Hip patients
aged 65 and older, however, had slightly higher odds of
choosing surgery after DA exposure compared with younger
patients (OR = 1.03, p = 0.9). Thus, we only find partial
support for our first hypothesis, as neither of these results
attained statistical significance at the p < 0.05 level. Hip and
knee patients with worse pain scores had somewhat greater
odds of choosing surgery post-DA relative to patients report-
ing less pain, supporting our second hypothesis (OR = 1.05,
p<0.01 and OR = 1.04, p<0.01, respectively). We find lower
odds for knee patients with high Charlson comorbidity scores
reporting a preference for surgery post-DA (OR = 0.93,
p<0.01), but no such relationship for hip patients, thus not
supporting our third hypothesis.
Results examining hip and knee patient treatment pre-
ferences among the three upstream implementing HVHC
systems are reported in Table 3 (n = 75 and n = 246,
respectively). One notable difference with primary analysis
findings concerns knee patients aged 65 and older who had
42% lower odds of preferring surgery post-DA compared
with patients 64 years of age and younger (compared with
21% reduced odds of choosing surgery in the full sample of
knee patients). The association between pain and comorbid-
ity with treatment preferences is similar to findings in the
main analysis, but with larger odds ratios.
Discussion
In a collaborative multi-system implementation of DAs,
we found that patient characteristics were associated with
patient preferences for surgery for hip and knee osteoar-
thritis. Hip and knee patients reporting high levels of pain
were most likely to have preferences for surgery post-DAs.
Notably, a greater proportion of knee patients than hip
patients reported increased certainty for their treatment
preference after completing DAs (13% vs 20%). These
findings are consistent with what has been reported in
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other pragmatic clinical settings examining the impact of
DAs upon treatment certainty.47
Nearly 20% of knee patients and 17% of hip patients in our
study remained uncertain about their treatment preferences
after viewing DAs (results not shown), which is higher than
levels reported in RCTs.14 One explanation for this divergent
finding concerns the selection of patients who received DAs
across HVHC systems. Given the non-randomized nature of
HVHC’s implementation of DAs, older hip patients who were
exposed to DAs may have been chosen based upon their
appropriateness as candidates for surgery instead of medical
management. Such a limitation has been noted elsewhere in
the SDM literature.38 Nonetheless, these results underscore
that routine implementation of SDM may not shift patient
preferences to the same extent as has been reported in RCTs
or non-pragmatic trials.28 Whereas RCTs have protocols that
are generally adhered to and monitored, pragmatic implemen-
tation occurs in organizational contexts where differences in
culture, the presence or lack of champions, and competing
demands are expected to influence the uptake (and success) of
engaging patients in shared decision making.
The introduction of DAs upstream in primary care may
allow for conversations of treatment tradeoffs that differ
from those that take place downstream in specialty care
settings. Previous work suggests that not only are patients’
general health histories better known to primary care
Table 1 Descriptive Statistics for DA Exposed Knee and Hip Patients Across All HVHC Systems
Knee (N = 1343) Hip (N = 495)
N % of Column Total N % of Column Total
Age (Mean, SD) 59.3 (9.6) 58.5 (10.1)
Gender
Female 869 64.7 278 56.1
Male 474 35.3 217 43.8
Race (vs White)
Non-White/Other 358 26.7 85 17.1
White 985 73.3 410 82.8
Marital Status
Unmarried 591 44 200 40.4
Married 752 56 295 59.6
Pre-DA Uncertain 384 28.6 117 23.6
Switched Preference Post-DA (from pre-DA choice)
Uncertain to Surgical 55 4.1 22 4.4
Uncertain to Non-Surgical 71 5.3 11 2.2
Othery 82 6.1 24 4.8
Stable Preferencesyy 1135 84.5 438 88.5
Decision Making Stage Post-DA
Increase 262 19.5 63 12.7
Stable 971 72.3 396 80
Decrease 85 6.3 29 5.9
Charlson Comorbidity Index (Mean, SD) 1.38 (2.00) 1.40 (2.79)
Pain Score (HOOS or KOOS) 52.7 (18.5) 54.8 (19.8)
Education Level
Less than/Graduated High School/GED 389 29 110 22.2
Some College/Graduated from College 699 52 277 56
Postgraduate Education 255 19 108 21.8
Notes: y Other includes patients switching from a surgical or non-surgical preference to uncertain, patients switching from a surgical preference to non-surgical preference
post-DA exposure, and patients switching from a non-surgical preference to surgical preference post-DA exposure. yy Includes patients who were continuously uncertain
(pre- and post-DA).
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physicians (PCPs), but PCPs are often better able to help
patients make treatment choices that are aligned with
personal values.48,49 Our sensitivity analysis reveals that
among upstream implementing systems, there is a strong
association between high pain scores and choice of surgery
post-DA among hip patients (OR = 1.19, p < 0.01, respec-
tively). To the extent that there is greater familiarity with
patients’ longitudinal experiences of pain in primary care
settings, conversations about a given patient’s appropriate-
ness for surgery may be carried out with better knowledge
of their general health status and other risk factors.
Importantly, our patient population tended to be under 65
(with a mean age of 58 among hip patients and 59 among
knee patients), which may also be a contributing factor to
patients choosing surgery over more conservative treat-
ment. Although few of our findings reached statistical
significance, we found associations of large magnitude
between patient characteristics and post-DA treatment pre-
ferences for upstream-implementing systems.
Our findings should be considered in light of some
limitations. First, our data were collected from an imple-
mentation study, thus precluding the possibility of con-
structing a “pure” unexposed control or comparison group.
Secondly, there was heterogeneity of the SDM intervention
across practice sites; some patients were prompted to view
a Health Dialog DVD DA or an online DA while other
practices invited patients to view the DA on an iPad. In
some instances, patients viewed DAs after rather than
Table 2 Association Between Patient Characteristics and Post-DA Surgical Choice, All HVHC Systems
Patients Choosing Surgery Post-DA
Knee (n = 648) Hip (n = 311)
Adjusted Model CI Adjusted Model CI
Age Age (Reference: 51–64) Age (Reference: 64 and under)
Under 50 0.89 0.60–1.32 N/A N/A
65+ 0.79 0.58–1.07 1.03 0.61–1.73
Gender
Female 0.57** 0.43–0.75 1.12 0.70–1.80
Male Ref Ref Ref Ref
Race (vs White)
Hispanic 1.27 0.77–2.08 0.87 0.20–3.71
Non-White/Other 1.15 0.81–1.63 0.79 0.43–1.48
White Ref Ref Ref Ref
Marital Status
Unmarried 1.00 0.76–1.31 0.52** 0.32–0.85
Married Ref Ref Ref Ref
Pre-DA Uncertainty 0.09** 0.06–1.14 0.06** 0.03–0.11
Switched Preference Post-DA (from pre-DA choice) 0.91 0.82–1.36 0.80 0.39–1.67
Decision Making Stage Post-DA
Stable 3.72** 2.06–6.69 1.07 0.29–2.69
Increase 0.89 0.28–4.57 0.89 0.41–2.80
Decrease Ref Ref Ref Ref
Charlson Comorbidity Index 0.93** 0.88–0.99 1.01 0.92–1.12
Pain Score (HOOS or KOOS) 1.04** 1.03–1.05 1.05** 1.03–1.06
Education Level
Some College/Graduated from College 1.15 0.76–1.73 1.33 0.74–2.39
Postgraduate Education 1.10 0.79–1.52
Less than/Graduated High School/GED Ref Ref Ref Ref
Note: **p<0.01.
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before their appointment with a specialist. These differences
alongside the extent to which SDM took place within these
encounters may have impacted our findings in ways that we
were unable to measure given a lack of documentation at
individual practice or physician/health care team levels. We
are not able to determine which specific patients within
upstream-implementing systems received DA in primary
versus specialty practices. However, since this shift tended
to occur earlier in the implementation, most patients com-
pleted DAs for primary care encounters in these three
systems. Finally, although our data are drawn from geogra-
phically diverse health systems, HVHC systems are not
representative of all health systems, and members pay fees
that support centralized data collection and reporting. Our
findings may not be generalizable to systems with fewer
resources and capacity for SDM and may face more chal-
lenges of implementing DAs.
Conclusion
In a multi-system project intended to routinely implement
the use of DAs to support SDM, we found that greater pain
was associated with greater odds of surgical preference
across both upstream and downstream-implementing sys-
tems. Older hip and knee patients within systems that
moved the DAs upstream into primary care had lower
odds of choosing surgery compared with older patients in
the overall sample of systems. Understanding nuances of
shifts in preferences across primary versus specialty care
Table 3 Association Between Patient Characteristics and Post-DA Surgical Choice, Upstream Implementing HVHC Systems Only
Adjusted
Model
Confidence Interval
(CI)
Adjusted
Model
CI
Knee Patients (n = 246) Hip Patients (n = 75)
Age Age (Reference: 51–64) Age (Reference: 64 and Under)
Under 50 0.77 0.27–2.19 N/A N/A
65+ 0.58 0.30–1.12 0.98 0.19–5.05
Gender
Female 0.66 0.32–1.37 0.86 0.11–6.70
Male Ref Ref
Race
Hispanic 0.93 0.15–5.63 N/A
Other/Non-white 0.94 0.23–3.84 1.85 0.15–23.45
White Ref Ref
Marital Status
Not Married 1.37 0.69–2.71 1.81 0.22–15.12
Married Ref Ref
Pre-DA Uncertainty 0.17** 0.07–0.43 <0.001* <0.001–0.05
Switched Preference Post-DA (frompre-DA choice) 1.32 0.45–3.83 1.91 0.06–65.58
Decision Making Stage
Stable 2.82 0.58–13.66 3.57 0.14–92.45
Increase 1.93 0.38–9.87 3.44 0.07–166.20
Decrease Ref Ref
Charlson Comorbidity Index 1.04 0.91–1.20 1.23 0.74–2.03
Pain Score 1.04** 1.02–1.06 1.19** 1.07–1.31
Education
Some College/College Graduate 1.47 0.71–3.04 6.34 0.89–45.20
Postgraduate Education 1.36 0.52–3.57 N/A N/A
Graduated High School Ref Ref
Notes: *p<0.05, **p<0.01.
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settings are needed to better support patients in the com-
plexity of decision-making for preference-sensitive condi-
tions. Pragmatic studies that compare the routine integration
of DAs into primary versus specialty care could further
clarify which groups of patients are most likely to find
DAs helpful in treatment decision-making processes, and
whether important differences exist across other patient-
centered outcomes such as decision certainty and regret.
Identifying mechanisms by which DAs can be complemen-
ted by such activities as health coaching, shared medical
appointments and care management50,51 to reduce decisio-
nal uncertainty could advance the optimal alignment of
treatment preferences and decisions for all patients.
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